DMAC Operating Cash Flow (Statement)
Diamedica Therapeutics Inc · Operating Cash Flow (Statement)
DMAC Operating Cash Flow (Statement)
Latest reported-$31.57Mperiod ending
DMAC TTM Cash from Operations (-$1.21M → -$31.57M)
TTM operating cash flow (statement)
High-resolution chart · PNG
DMAC operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -31,565,860 | |
| -31,049,860 | |
| -29,116,860 | |
| -27,785,860 | |
| -25,651,000 | |
| -22,572,000 | |
| -22,076,000 | |
| -19,454,000 | |
| -19,781,000 | |
| -20,292,000 | |
| -18,728,000 | |
| -17,682,000 | |
| -15,246,000 | |
| -12,712,000 | |
| -11,511,000 | |
| -11,549,000 | |
| -12,234,000 | |
| -11,827,000 | |
| -12,252,000 | |
| -12,464,000 | |
| -11,765,000 | |
| -10,520,000 | |
| -9,185,000 | |
| -8,034,000 | |
| -6,919,000 | |
| -8,946,000 | |
| -9,102,000 | |
| -9,147,886 | |
| -9,772,615 | |
| -7,925,761 | |
| -5,696,000 | |
| -4,759,939 | |
| -3,582,233 | |
| -3,981,033 | |
| -3,900,000 | |
| -4,203,787 | |
| -4,449,223 | |
| -3,427,395 | |
| -3,023,179 | |
| -2,090,206 | |
| -1,264,380 | |
| -1,445,709 | |
| -1,365,931 | |
| -1,144,478 | |
| -1,613,253 | |
| -2,954,876 | |
| -3,755,675 | |
| -4,080,506 | |
| -4,634,879 | |
| -4,775,140 | |
| -5,502,606 | |
| -6,497,549 | |
| -7,331,571 | |
| -6,667,526 | |
| -5,483,825 | |
| -5,291,713 | |
| -4,147,418 | |
| -3,460,494 | |
| -3,436,017 | |
| -2,712,286 | |
| -1,508,013 | |
| -2,733,038 | |
| -2,376,769 | |
| -2,330,994 | |
| -3,297,761 | |
| -1,986,031 | |
| -2,146,707 | |
| -1,761,050 | |
| -1,928,322 | |
| -1,933,475 | |
| -1,466,355 | |
| -1,562,808 | |
| -1,525,553 | |
| -1,062,077 | |
| -1,213,352 | |
| -1,246,380 |